-
1
-
-
0034256946
-
Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats Implications for tardive dyskinesia?
-
O.A. Andreassen, and H.A. Jorgensen Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats Implications for tardive dyskinesia? Prog. Neurobiol. 61 2000 525 541
-
(2000)
Prog. Neurobiol.
, vol.61
, pp. 525-541
-
-
Andreassen, O.A.1
Jorgensen, H.A.2
-
2
-
-
13444269543
-
Haploview: Analysis and visualization of LD and haplotype maps
-
J.C. Barrett, B. Fry, J. Maller, and M.J. Daly Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 2005 263 265
-
(2005)
Bioinformatics
, vol.21
, pp. 263-265
-
-
Barrett, J.C.1
Fry, B.2
Maller, J.3
Daly, M.J.4
-
3
-
-
0032982269
-
Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia
-
V.S. Basile, M. Masellis, F. Badri, A.D. Paterson, H.Y. Meltzer, J.A. Lieberman, S.G. Potkin, F. Macciardi, and J.L. Kennedy Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia Neuropsychopharmacology 21 1999 17 27
-
(1999)
Neuropsychopharmacology
, vol.21
, pp. 17-27
-
-
Basile, V.S.1
Masellis, M.2
Badri, F.3
Paterson, A.D.4
Meltzer, H.Y.5
Lieberman, J.A.6
Potkin, S.G.7
MacCiardi, F.8
Kennedy, J.L.9
-
4
-
-
0033939932
-
A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: Association with tardive dyskinesia in schizophrenia
-
V.S. Basile, V. Özdemir, M. Masellis, M.L. Walker, H.Y. Meltzer, J.A. Lieberman, S.G. Potkin, G. Alva, W. Kalow, F.M. Macciardi, and J.L. Kennedy A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia Mol. Psychiatry 5 2000 410 417
-
(2000)
Mol. Psychiatry
, vol.5
, pp. 410-417
-
-
Basile, V.S.1
Özdemir, V.2
Masellis, M.3
Walker, M.L.4
Meltzer, H.Y.5
Lieberman, J.A.6
Potkin, S.G.7
Alva, G.8
Kalow, W.9
MacCiardi, F.M.10
Kennedy, J.L.11
-
6
-
-
0035988588
-
Vitamin e and neurodegenerative disorders associated with oxidative stress
-
D.A. Butterfield, A. Castegna, J. Drake, G. Scapagnini, and V. Calabrese Vitamin E and neurodegenerative disorders associated with oxidative stress Nutr. Neurosci. 5 2002 229 239
-
(2002)
Nutr. Neurosci.
, vol.5
, pp. 229-239
-
-
Butterfield, D.A.1
Castegna, A.2
Drake, J.3
Scapagnini, G.4
Calabrese, V.5
-
8
-
-
0028569188
-
Molecular psychiatry adaptations of receptor-coupled signal transduction pathways underlying stress- and drug-induced neural plasticity
-
R.S. Duman, G.R. Heninger, and E.J. Nestler Molecular psychiatry adaptations of receptor-coupled signal transduction pathways underlying stress- and drug-induced neural plasticity J. Nerv. Ment. Dis. 182 1994 692 700
-
(1994)
J. Nerv. Ment. Dis.
, vol.182
, pp. 692-700
-
-
Duman, R.S.1
Heninger, G.R.2
Nestler, E.J.3
-
9
-
-
0003364685
-
Abnormal involuntary movement scale (AIMS)
-
Department Health, Education and Welfare, DC, US DWEW Publication Washington
-
W. Guy Abnormal involuntary movement scale (AIMS) ECDEU Assessment Manual for Psychopharmacology (revised) 1976 Department Health, Education and Welfare, DC, US DWEW Publication Washington pp. 534-537
-
(1976)
ECDEU Assessment Manual for Psychopharmacology (Revised)
-
-
Guy, W.1
-
10
-
-
0031427094
-
Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer
-
L.W. Harries, M.J. Stubbins, D. Forman, G.C. Howard, and C.R. Wolf Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer Carcinogenesis 18 1997 641 644
-
(1997)
Carcinogenesis
, vol.18
, pp. 641-644
-
-
Harries, L.W.1
Stubbins, M.J.2
Forman, D.3
Howard, G.C.4
Wolf, C.R.5
-
11
-
-
0034096258
-
Manganese superoxide dismutase gene polymorphism and schizophrenia: Relation to tardive dyskinesia
-
H. Hori, O. Ohmori, T. Shinkai, H. Kojima, C. Okano, T. Suzuki, and J. Nakamura Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia Neuropsychopharmacology 23 2000 170 177
-
(2000)
Neuropsychopharmacology
, vol.23
, pp. 170-177
-
-
Hori, H.1
Ohmori, O.2
Shinkai, T.3
Kojima, H.4
Okano, C.5
Suzuki, T.6
Nakamura, J.7
-
12
-
-
0032401820
-
Catalytic efficiencies of allelic variants of human glutathione S-transferase P1-1 toward carcinogenic anti-diol epoxides of benzo[c]phenanthrene and benzo[g]chrysene
-
X. Hu, H. Xia, S.K. Srivastava, A. Pal, Y.C. Awasthi, P. Zimniak, and S.V. Singh Catalytic efficiencies of allelic variants of human glutathione S-transferase P1-1 toward carcinogenic anti-diol epoxides of benzo[c]phenanthrene and benzo[g]chrysene Cancer Res. 58 1998 5340 5343
-
(1998)
Cancer Res.
, vol.58
, pp. 5340-5343
-
-
Hu, X.1
Xia, H.2
Srivastava, S.K.3
Pal, A.4
Awasthi, Y.C.5
Zimniak, P.6
Singh, S.V.7
-
13
-
-
0032800636
-
Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease
-
T. Ishii, T. Matsuse, S. Teramoto, H. Matsui, M. Miyao, T. Hosoi, H. Takahashi, Y. Fukuchi, and Y. Ouchi Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease Thorax 54 1999 693 696
-
(1999)
Thorax
, vol.54
, pp. 693-696
-
-
Ishii, T.1
Matsuse, T.2
Teramoto, S.3
Matsui, H.4
Miyao, M.5
Hosoi, T.6
Takahashi, H.7
Fukuchi, Y.8
Ouchi, Y.9
-
14
-
-
0034996936
-
Glutathione S-transferase Pi is a dopamine-inducible suppressor of dopamine-induced apoptosis in PC12 cells
-
A. Ishisaki, H. Hayashi, S. Suzuki, K. Ozawa, E. Mizukoshi, K. Miyakawa, M. Suzuki, and T. Imamura Glutathione S-transferase Pi is a dopamine-inducible suppressor of dopamine-induced apoptosis in PC12 cells J. Neurochem. 77 2001 1362 1371
-
(2001)
J. Neurochem.
, vol.77
, pp. 1362-1371
-
-
Ishisaki, A.1
Hayashi, H.2
Suzuki, S.3
Ozawa, K.4
Mizukoshi, E.5
Miyakawa, K.6
Suzuki, M.7
Imamura, T.8
-
15
-
-
0030898607
-
Schizophrenia, tardive dyskinesia, and a D3 receptor gene variant: A new twist on dyskinesias?
-
D.V. Jeste, and J.R. Kelsoe Schizophrenia, tardive dyskinesia, and a D3 receptor gene variant: a new twist on dyskinesias? Mol. Psychiatry 2 1997 86 88
-
(1997)
Mol. Psychiatry
, vol.2
, pp. 86-88
-
-
Jeste, D.V.1
Kelsoe, J.R.2
-
16
-
-
0020054615
-
Tardive dyskinesia: Prevalence and risk factors, 1959 to 1979
-
J.M. Kane, and J.M. Smith Tardive dyskinesia: prevalence and risk factors, 1959 to 1979 Arch. Gen. Psychiatry 39 1982 473 481
-
(1982)
Arch. Gen. Psychiatry
, vol.39
, pp. 473-481
-
-
Kane, J.M.1
Smith, J.M.2
-
17
-
-
0032572604
-
Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia
-
T. Kapitany, K. Meszaros, E. Lenzinger, S.D. Schindler, C. Barnas, K. Fuchs, W. Sieghart, H.N. Aschauer, and S. Kasper Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia Schizophr. Res. 32 1998 101 106
-
(1998)
Schizophr. Res.
, vol.32
, pp. 101-106
-
-
Kapitany, T.1
Meszaros, K.2
Lenzinger, E.3
Schindler, S.D.4
Barnas, C.5
Fuchs, K.6
Sieghart, W.7
Aschauer, H.N.8
Kasper, S.9
-
18
-
-
0035130571
-
Differential and region-specific activation of mitogen-activated protein kinases following chronic administration of phencyclidine in rat brain
-
S.V. Kyosseva, S.M. Owens, A.D. Elbein, and C.N. Karson Differential and region-specific activation of mitogen-activated protein kinases following chronic administration of phencyclidine in rat brain Neuropsychopharmacology 24 2001 267 277
-
(2001)
Neuropsychopharmacology
, vol.24
, pp. 267-277
-
-
Kyosseva, S.V.1
Owens, S.M.2
Elbein, A.D.3
Karson, C.N.4
-
19
-
-
0026080111
-
A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies
-
D.K. Lahiri, and J.I. Nurnberger Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies Nucleic Acids Res. 19 1991 5444
-
(1991)
Nucleic Acids Res.
, vol.19
, pp. 5444
-
-
Lahiri, D.K.1
Nurnberger Jr., J.I.2
-
20
-
-
0036283004
-
Pharmacogenetics of tardive dyskinesia: Combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism
-
B. Lerer, R.H. Segman, H. Fangerau, A.K. Daly, V.S. Basile, R. Cavallaro, H.N. Aschauer, R.G. McCreadie, S. Ohlraun, N. Ferrier, M. Masellis, M. Verga, J. Scharfetter, M. Rietschel, R. Lovlie, U.H. Levy, H.Y. Meltzer, J.L. Kennedy, V.M. Steen, and F. Macciardi Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism Neuropsychopharmacology 27 2002 105 119
-
(2002)
Neuropsychopharmacology
, vol.27
, pp. 105-119
-
-
Lerer, B.1
Segman, R.H.2
Fangerau, H.3
Daly, A.K.4
Basile, V.S.5
Cavallaro, R.6
Aschauer, H.N.7
McCreadie, R.G.8
Ohlraun, S.9
Ferrier, N.10
Masellis, M.11
Verga, M.12
Scharfetter, J.13
Rietschel, M.14
Lovlie, R.15
Levy, U.H.16
Meltzer, H.Y.17
Kennedy, J.L.18
Steen, V.M.19
MacCiardi, F.20
more..
-
21
-
-
0025125631
-
Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia
-
J.B. Lohr, R. Kuczenski, H.S. Bracha, M. Moir, and D.V. Jeste Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia Biol. Psychiatry 28 1990 535 539
-
(1990)
Biol. Psychiatry
, vol.28
, pp. 535-539
-
-
Lohr, J.B.1
Kuczenski, R.2
Bracha, H.S.3
Moir, M.4
Jeste, D.V.5
-
22
-
-
0028114486
-
An overview of the mechanism of action of clozapine
-
H.Y. Meltzer An overview of the mechanism of action of clozapine J. Clin. Psychiatry (Suppl. B) 55 1994 47 52
-
(1994)
J. Clin. Psychiatry (Suppl. B)
, vol.55
, pp. 47-52
-
-
Meltzer, H.Y.1
-
23
-
-
0027244076
-
Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications Results of the Yale Tardive Dyskinesia Study
-
H. Morgenstern, and W.M. Glazer Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications Results of the Yale Tardive Dyskinesia Study Arch. Gen. Psychiatry 50 1993 723 733
-
(1993)
Arch. Gen. Psychiatry
, vol.50
, pp. 723-733
-
-
Morgenstern, H.1
Glazer, W.M.2
-
24
-
-
0024549495
-
Structure of the human genomic glutathione S-transferase-pi gene
-
C.S. Morrow, K.H. Cowan, and M.E. Goldsmith Structure of the human genomic glutathione S-transferase-pi gene Gene 75 1989 3 11
-
(1989)
Gene
, vol.75
, pp. 3-11
-
-
Morrow, C.S.1
Cowan, K.H.2
Goldsmith, M.E.3
-
26
-
-
0036273891
-
Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: Possible antioxidant mechanisms
-
P.S. Naidu, A. Singh, and S.K. Kulkarni Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms Br. J. Clin. Pharmacol. 136 2002 193 200
-
(2002)
Br. J. Clin. Pharmacol.
, vol.136
, pp. 193-200
-
-
Naidu, P.S.1
Singh, A.2
Kulkarni, S.K.3
-
27
-
-
0038030618
-
Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia
-
P.S. Naidu, A. Singh, and S.K. Kulkarni Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia Neuropharmacology 44 2003 1100 1106
-
(2003)
Neuropharmacology
, vol.44
, pp. 1100-1106
-
-
Naidu, P.S.1
Singh, A.2
Kulkarni, S.K.3
-
28
-
-
0038689141
-
A perspective on molecular genetic studies of tardive dyskinesia: One clue for individualized antipsychotic drug therapy
-
O. Ohmori, T. Shinkai, H. Hori, C. Matsumoto, and J. Nakamura A perspective on molecular genetic studies of tardive dyskinesia: one clue for individualized antipsychotic drug therapy Prog. Neuropsychopharmacol. Biol. Psychiatry 27 2003 581 586
-
(2003)
Prog. Neuropsychopharmacol. Biol. Psychiatry
, vol.27
, pp. 581-586
-
-
Ohmori, O.1
Shinkai, T.2
Hori, H.3
Matsumoto, C.4
Nakamura, J.5
-
29
-
-
0032572599
-
Tardive dyskinesia and debrisoquine 4-hydroxylase (CYP2D6) genetype in Japanese schizophrenics
-
O. Ohmori, T. Suzuki, H. Kojima, T. Shinkai, T. Terao, T. Mita, and K. Abe Tardive dyskinesia and debrisoquine 4-hydroxylase (CYP2D6) genetype in Japanese schizophrenics Schizophr. Res. 32 1998 107 113
-
(1998)
Schizophr. Res.
, vol.32
, pp. 107-113
-
-
Ohmori, O.1
Suzuki, T.2
Kojima, H.3
Shinkai, T.4
Terao, T.5
Mita, T.6
Abe, K.7
-
30
-
-
0024490605
-
Glutathione transferases as markers of preneoplasia and neoplasia
-
K. Sato Glutathione transferases as markers of preneoplasia and neoplasia Adv. Cancer Res. 52 1989 205 255
-
(1989)
Adv. Cancer Res.
, vol.52
, pp. 205-255
-
-
Sato, K.1
-
31
-
-
0020034360
-
Research diagnoses for tardive dyskinesia
-
N.R. Schooler, and J.M. Kane Research diagnoses for tardive dyskinesia Arch. Gen. Psychiatry 39 1982 486 487
-
(1982)
Arch. Gen. Psychiatry
, vol.39
, pp. 486-487
-
-
Schooler, N.R.1
Kane, J.M.2
-
32
-
-
0025875705
-
Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride
-
R.E. See Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride Neurosci. Lett. 129 1991 265 268
-
(1991)
Neurosci. Lett.
, vol.129
, pp. 265-268
-
-
See, R.E.1
-
33
-
-
17744392199
-
Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia
-
R.H. Segman, U. Heresco-Levy, B. Finkel, T. Goltser, R. Shalem, M. Schlafman, A. Dorevitch, A. Yakir, D. Greenberg, A. Lerner, and B. Lerer Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia Mol. Psychiatry 6 2001 225 229
-
(2001)
Mol. Psychiatry
, vol.6
, pp. 225-229
-
-
Segman, R.H.1
Heresco-Levy, U.2
Finkel, B.3
Goltser, T.4
Shalem, R.5
Schlafman, M.6
Dorevitch, A.7
Yakir, A.8
Greenberg, D.9
Lerner, A.10
Lerer, B.11
-
34
-
-
0033667902
-
gly alleles to susceptibility
-
gly alleles to susceptibility Psychopharmacology 152 2000 408 413
-
(2000)
Psychopharmacology
, vol.152
, pp. 408-413
-
-
Segman, R.H.1
Heresco-Levy, U.2
Finkel, B.3
Inbar, R.4
Neeman, T.5
Schlafman, M.6
Dorevitch, A.7
Yakir, A.8
Lerner, A.9
Goltser, T.10
Shelevoy, A.11
Lerer, B.12
-
36
-
-
0030903368
-
Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients
-
V.M. Steen, R. Løvlie, T. MacEwan, and R.G. McCreadie Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients Mol. Psychiatry 2 1997 139 145
-
(1997)
Mol. Psychiatry
, vol.2
, pp. 139-145
-
-
Steen, V.M.1
Løvlie, R.2
MacEwan, T.3
McCreadie, R.G.4
-
37
-
-
0017396773
-
The pathophysiologic basis of tardive dyskinesia
-
D. Tarsy, and R.J. Baldessarini The pathophysiologic basis of tardive dyskinesia Biol. Psychiatry 12 1977 431 450
-
(1977)
Biol. Psychiatry
, vol.12
, pp. 431-450
-
-
Tarsy, D.1
Baldessarini, R.J.2
-
38
-
-
79959503826
-
The International HapMap Project
-
The International HapMap Consortium, The International HapMap Project, Nature 426 (2003) 789-796.
-
(2003)
Nature
, vol.426
, pp. 789-796
-
-
-
39
-
-
0031695231
-
Markers of glutamatergic neurotransmission and oxidative stress associated tardive dyskinesia
-
G. Tsai, D.C. Goff, R.W. Chang, J. Flood, L. Baer, and J.T. Coyle Markers of glutamatergic neurotransmission and oxidative stress associated tardive dyskinesia Am. J. Forensic Psychiatry 155 1998 1207 1213
-
(1998)
Am. J. Forensic Psychiatry
, vol.155
, pp. 1207-1213
-
-
Tsai, G.1
Goff, D.C.2
Chang, R.W.3
Flood, J.4
Baer, L.5
Coyle, J.T.6
-
40
-
-
0031878594
-
Human glutathione S-transferase P1 polymorphisms: Relationship to lung tissue enzyme activity and population frequency distribution
-
M.A. Watson, R.K. Stewart, G.B. Smith, T.E. Massey, and D.A. Bell Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution Carcinogenesis 19 1998 275 280
-
(1998)
Carcinogenesis
, vol.19
, pp. 275-280
-
-
Watson, M.A.1
Stewart, R.K.2
Smith, G.B.3
Massey, T.E.4
Bell, D.A.5
-
42
-
-
0036019989
-
The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism
-
Z. Zhang, X. Zhang, G. Hou, W. Sha, and G.P. Reynolds The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism J. Psychiatr. Res. 36 2002 317 324
-
(2002)
J. Psychiatr. Res.
, vol.36
, pp. 317-324
-
-
Zhang, Z.1
Zhang, X.2
Hou, G.3
Sha, W.4
Reynolds, G.P.5
|